Maplelane Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,825,000
Closed -$34.3M 143
2019
Q2
$34.3M Buy
+1,825,000
New +$34.6M 0.73% 35
2019
Q1
Sell
-1,300,000
Closed -$17.7M 134
2018
Q4
$17.7M Buy
+1,300,000
New +$18.6M 0.51% 46

Other funds holding LRCX

Maplelane Capital's LRCX Position: Q1 2026 in Review

Maplelane Capital increased its Lam Research (LRCX) stake by 265% in Q1 2026, buying an estimated $101M and bringing the position to 621,000 shares worth $133M. The position accounts for 4.75% of the portfolio, ranked #5.

Maplelane Capital first reported a position in LRCX in Q4 2014 and has held it in 18 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Maplelane Capital held 621,000 shares of Lam Research worth $133M as of Q1 2026.
  • Maplelane Capital bought 451,000 Lam Research shares in Q1 2026, an estimated $101M.
  • Lam Research made up 4.75% of Maplelane Capital's portfolio in Q1 2026, its #5 holding.
  • Maplelane Capital first reported a position in Lam Research in Q4 2014 and has held it in 18 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Maplelane Capital's 13F filing for Q1 2026, filed 14 May 2026.